Sponsor hub

The Cleveland Clinic clinical trial failures

Review 65 stopped clinical trials from The Cleveland Clinic, including disease areas, phases, and classified stop reasons.

This page groups real ClinicalTrials.gov-derived stopped trial records. The strongest added signal is the stop-reason classification: 4 of these records are likely biological failure signals, while the rest may reflect operational, strategic, regulatory, funding, enrollment, or unclear stop reasons.

Total stopped trials65
Likely biological signals4
Shown below65

Dominant stop reasons

OPERATIONAL
35
OTHER/UNKNOWN
26
EFFICACY/FUTILITY
4

Notable sponsors

The Cleveland Clinic
65

Related phases

Unknown
25
Phase IV
18
Phase II
8
Phase I
7
Phase III
4

Crawlable stopped-trial records

Open Explore

Showing up to 65 representative records from this slice. Each link opens the trial detail page with source attribution and stop-reason context.

NCT04531176: EMI-EHP Weight Management and Type 2 Diabetes Pragmatic Trial

Phase IV Type 2 Diabetes trial by The Cleveland Clinic. Stop reason: EFFICACY/FUTILITY.

After an unplanned yet IRB approved interim analysis, it was found that there was not a significant difference between the 3 arms of the study. The study was closed due to futility. All Patients are off study and this study will not resume.